Usana Health Sciences, Inc., a Utah-based nutritional, skincare and dietary products manufacturer, indicates in its recently filed 8-K that it has substantially completed an internal investigation into whether the expense reimbursement policy and other practices at its Chinese affiliate, BabyCare Ltd., were compliant with the Foreign Corrupt Practices Act. The company reports that it is cooperating with the DOJ and the SEC in their investigations of the matter.
February 5, 2019
DOJ and SEC investigating nutritional supplement maker for possible FCPA violations
Related by Topic
New Post
Texas businessman pleads guilty to FCPA violations involving a Mexican official
April 2, 2026
News Alert
New Post
Mining company notifies SEC and DOJ of possible FCPA violations by an Indonesian affiliate
March 30, 2026
News Alert
New Post
DOJ declines to prosecute medical device company Balt for FCPA violations
March 25, 2025
News Alert